The Biden-Harris Administration, through the Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS), announced it has initiated the first cycle of the Medicare Drug Price Negotiation Program. This program, established by the Inflation Reduction Act (IRA), empowers Medicare to directly negotiate prescription drug prices with pharmaceutical companies, similar to other federal agencies. The initial… (Colocho, February 1, 2024) #Costs, #Drug Pricing, #Public Health, #Transparency